Ethris, based in the biotech hub of Munich/Planegg, Germany, is a leading innovator in the field of messenger RNA (mRNA). We are dedicated to developing next-generation mRNA-based therapeutics and vaccines for respiratory diseases, leveraging our technology to replace or supplement missing or non-functional proteins and introduce new proteins to modulate disease progression or symptoms. Working at the forefront of medical innovation, we see this as a once-in-a-lifetime opportunity to rethink human therapeutics and vaccines. Our diverse and skilled team of around 50 professionals shares a common goal: revolutionizing medicine and bringing groundbreaking therapies to patients worldwide.
APCT1_DE